Company
Sanofi
Headquarters: Paris, France
Founded: 1973
Employees: 95,442
CEO: Mr. Paul Hudson
Market Cap
€116.03 Billion
EUR as of Jan. 1, 2024
US$128.15 Billion
Company Description
Sanofi, along with its subsidiaries, is involved in the research, development, manufacture, and marketing of various therapeutic solutions. It operates in three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. It offers a wide range of products for specialty care, diabetes, cardiovascular issues, and provides vaccines for various diseases, consumer healthcare products, wellness, probiotics, digestive, and nutritional products.
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—General
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
| AbbVie | $285.06 B |
| Roche | $240.44 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Top 1-year algo backtest: +298.72%
$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Sanofi has the following listings and related stock indices.
Stock: Euronext: SAN wb_incandescent
Stock: BMV: SNYN wb_incandescent
Stock: FSX: SNW wb_incandescent
Stock: FSX: SNW2 wb_incandescent
Stock: MTA: SANF wb_incandescent
Stock: OTC: SNYNF wb_incandescent
Stock: NASDAQ: SNY wb_incandescent
Stock: XETR: SNW wb_incandescent
Product & Services
Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health (list...)
Key People
Founder(s): Elf Aquitaine
Serge Weinberg (Chairman) Paul Hudson (CEO)
Financials
Revenue: €36.12 billion (2020)
Operating income: €15.50 billion (2020)
Net income: €12.35 billion (2020)
Total assets: €115.75 billion (2020)
Total equity: €60.10 billion (2020)